This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Expedia, Citigroup, Target: New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

BJ's Wholesale (BJ) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company also added to the Conviction List and earnings growth should accelerate. $59 price target.

Bruker (BRKR - Get Report) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $23 price target. Valuation call, as the stock is up 44% over the past 12 months.

Bally Technologies (BYI - Get Report) downgraded at Keybanc from Buy to Hold, Keybanc said. Company cut its earnings guidance.

Bally Technologies (BYI - Get Report) downgraded at Credit Suisse to Neutral from Outperform as management cut 2011 guidance, Credit Suisse said. Price target dropped to $40 from $47.

Bally Technologies (BYI - Get Report) estimates reduced at Goldman through 2013, Goldman Sachs said. Company is realizing lower gaming margins. Sell rating and $32 price target.

Citigroup (C - Get Report) rated new Buy at Sterne Agee. $6 price target. Company is leveraged to growth in emerging markets.

Costco (COST) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call, based on an $80 price target.

Devry (DV - Get Report) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Estimates also cut, as industry fundamentals are weakening. $60 price target.

Expedia (EXPE) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $35 price target. TripAdvisor spin-off should unlock value.

Incyte (INCY) upgraded at UBS from Neutral to Buy, UBS said. $20 price target. Estimates also upped, as the company can manage through increased competition.

JP Morgan (JPM - Get Report) rated new Buy at Sterne Agee. $55 price target. Company has a strong balance sheet and is leveraged to an economic recovery.

Lennox International (LII) downgraded at Keybanc from Buy to Hold, Keybanc said. Taking a more cautious stance on the HVAC market.

Medtronic (MDT) rated new Buy at Wunderlich. $46 price target. Company is a market leader and should soon find a new CEO.

PF Chang's (PFCB) rated new Outperform at Wells Fargo. Company has two successful brands and should continue to grow.

Parametric Technology (PMTC) upgraded at Jefferies to Buy. $28 price target. Company has multiple potential catalysts.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BYI $83.27 0.00%
BRKR $19.61 0.00%
C $53.07 0.00%
DV $35.88 0.00%
EXP $83.57 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs